Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).
- Conditions
- Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Celgene
- Target Recruit Count
- 31
- Registration Number
- NCT01835587
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center., New York, New York, United States
🇺🇸University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸MD Anderson Cancer Center The University of Texas, Houston, Texas, United States
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Other: Supportive Care
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Annie Im, M.D.
- Target Recruit Count
- 44
- Registration Number
- NCT01829503
- Locations
- 🇺🇸
University of PIttsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Target Recruit Count
- 119
- Registration Number
- NCT01819792
- Locations
- 🇫🇷
Pr Marolleau, Amiens, France
🇫🇷CHU CAEN, Caen, France
🇫🇷Chru Lille, Lille, France
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
- Conditions
- Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)
- Interventions
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Gamida Cell ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01816230
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Loyola University, Cardinal Bernardin Cancer Center, Maywood, Illinois, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 74
- Registration Number
- NCT01786343
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
- Conditions
- Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
- Interventions
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2016-10-12
- Target Recruit Count
- 40
- Registration Number
- NCT01772953
- Locations
- 🇺🇸
Children's Hospital of Alabama/UAB, Birmingham, Alabama, United States
🇺🇸Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸City of Hope, Duarte, California, United States
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2013-01-17
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- University of Ulm
- Target Recruit Count
- 8
- Registration Number
- NCT01770158
- Locations
- 🇩🇪
Vivantes Hospital Neukölln, Berlin, Germany
🇩🇪Charite, University Medical School of Berlin, Berlin, Germany
🇩🇪Darmstadt Clinic, Darmstadt, Germany
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Celgene
- Target Recruit Count
- 472
- Registration Number
- NCT01757535
- Locations
- 🇺🇸
Arizona Oncology Associates, P.C., Phoenix, Arizona, United States
🇺🇸Providence St Joseph Medical Center Cancer Center, Burbank, California, United States
🇺🇸City Of Hope, Duarte, California, United States
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
- Conditions
- Chronic Kidney DiseaseMultiple MyelomaAcute Myeloid Leukemia (AML)Chronic Myelogenous Leukemia (CML)Aplastic AnemiaAL AmyloidosisChronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL)Myelodysplastic Syndrome (MDS)Myelofibrosis
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01758042
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
- Conditions
- MDS and AML Prior to Allogeneic SCT
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 134
- Registration Number
- NCT01746147
- Locations
- 🇩🇪
III. Medizinischen Klinik Hämatologie und Internistische Onkologie Universitätsmedizin Mannheim, Mannheim, Baden-Württemberg, Germany
🇩🇪III. Medizinischen Klinik des Klinikums rechts der Isar, München, Bayern, Germany
🇩🇪Universitätsklinikum MKII, Hämatologie/Onkologie, Universitäres Zentrum für Tumorerkrankungen, Frankfurt, Hessen, Germany